Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
It works by targeting multiple hormone receptors in the body, including GLP-1, GIP, and glucagon receptors
The escalating global prevalence of Type 2 Diabetes Mellitus and obesity stands as the foremost driver for the robust expansion of the market
A powerful dual-action treatment that mimics two hormones to help suppress appetite, regulate blood sugar, and improve fat metabolism
.png.jpg)
The question of whether GLP-1 receptor agonists might increase pancreatic cancer risk emerged from preclinical animal studies and early post-marketing surveillance reports
A personalized approach considering individual bone and cardiovascular risk profiles is essential when prescribing GLP-1RAs to women, particularly those with osteoporosis or high cardiovascular risk
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
